PRECLINICAL CHARACTERIZATION OF PROSETIN, A BRAIN-PENETRANT MAP4K INHIBITOR FOR TREATING ALS
$1,619,986FY2021Defense Health AgencyDOD
The Trustees Of Columbia University In The City Of New York
The Trustees Of Columbia University In The City Of New York